Factors associated with incident ischemic stroke in hospitalized heart failure patients: A pilot study

Hypertension Research

Volumn 31, Issue 2, 2008, Pages 289-294

  Komori, Takahiro ^a,b   Eguchi, Kazuo ^b   Tomizawa, Hidenori ^b   Ishikawa, Joji ^b   Hoshide, Satoshi ^b   Shimada, Kazuyuki ^b   Kario, Kazuomi ^b  

^a Utsunomiya Social Insurance Hospital   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Brain type natriuretic peptide; Congestive heart failure; Nocturnal blood pressure; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; TICLOPIDINE; WARFARIN;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CEREBROVASCULAR ACCIDENT; CIRCADIAN RHYTHM; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; BRAIN ISCHEMIA; CIRCADIAN RHYTHM; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PILOT PROJECTS; STROKE;

EID: 41549134658     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.289     Document Type: Article

References (30)

1. Rosamond W, Flegal K, Friday G, et al: Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115: e69-e171.
2. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD: Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002; 39: 60-69.
3. Levy D, Kenchaiah S, Larson MG, et al: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-1402.
4. Siachos T, Vanbakel A, Feldman DS, Uber W, Simpson KN, Pereira NL: Silent strokes in patients with heart failure. J Card Fail 2005; 11: 485-489.
5. Pullicino PM, Halperin JL, Thompson JL: Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology 2000; 54: 288-294.
6. Wilhelmsen L, Rosengren A, Eriksson H, Lappas G: Heart failure in the general population of men - morbidity, risk factors and prognosis. J Intern Med 2001; 249: 253-261.
7. Goldstein LB, Adams R, Alberts MJ, et al: Primary prevention of ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 1583-1633.
8. Koniaris L, Goldhaber S: Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol 1998; 31: 745-748.
9. Freudenberger RS, Massie BM: Silent cerebral infarction in heart failure: vascular or thromboembolic? J Card Fail 2005; 11: 490-491.
10. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
11. Sokolow M, Lyon TP: The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37: 161-186.
12. Imai Y, Sasaki S, Minami N, et al: The accuracy and performance of the A&D TM 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens 1992; 5: 719-726.
13. Teichholz LE, Kreulen T, Herman MV, Gorlin R: Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7-11.
14. Pickering TG, Hall JE, Appel LJ, et al: Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111: 697-716.
15. Staessen JA, Asmar R, De Buyzere M, et al: Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit 2001; 6: 355-370.
16. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
17. Kizer JR, Wiebers DO, Whisnant JP, et al: Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study. Stroke 2005; 36: 2533-2537.
18. Lee TT, Chen J, Cohen DJ, Tsao L: The association between blood pressure and mortality in patients with heart failure. Am Heart J 2006; 151: 76-83.
19. Canesin MF, Giorgi D, Oliveira MT Jr, et al: Ambulatory blood pressure monitoring of patients with heart failure. A new prognosis marker. Arq Bras Cardiol 2002; 78: 83-89.
20. Goyal D, Macfadyen RJ, Watson RD, Lip GY: Ambulatory blood pressure monitoring in heart failure: a systematic review. Eur J Heart Fail 2005; 7: 149-156.
21. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K: Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38: 852-857.
22. Ohkubo T, Imai Y, Tsuji I, et al: Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens 1997; 10: 1201-1207.
23. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K: Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-135.
24. Verdecchia P, Schillaci G, Borgioni C, et al: Altered circadian blood pressure profile and prognosis. Blood Press Monit 1997; 2: 347-352.
25. Hoshide S, Ishikawa J, Eguchi K, Ojima T, Shimada K, Kario K: Masked nocturnal hypertension and target organ damage in hypertensives with well-controlled self-measured home blood pressure. Hypertens Res 2007; 30: 143-149.
26. Nakano S, Ito T, Furuya K, et al: Ambulatory blood pressure level rather than dipper/nondipper status predicts vascular events in type 2 diabetic subjects. Hypertens Res 2004; 27: 647-656.
27. Eto M, Toba K, Akishita M, et al: Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension. Hypertens Res 2005; 28: 1-7.
28. Doust JA, Pietrzak E, Dobson A, Glasziou P: How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005; 330: 625.
29. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ: Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol 1997; 29: 1074-1080.
30. Sanderson JE: Heart failure with a normal ejection fraction. Heart 2007; 93: 155-158.